904 related articles for article (PubMed ID: 27261457)
1. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
[TBL] [Abstract][Full Text] [Related]
3. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
[TBL] [Abstract][Full Text] [Related]
4. DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.
Sato K; Yamashita-Kanemaru Y; Abe F; Murata R; Nakamura-Shinya Y; Kanemaru K; Muratani M; Veillette A; Goto M; Ito M; Shibuya A; Shibuya K
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011606
[TBL] [Abstract][Full Text] [Related]
5. PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.
Li Z; Lin F; Zhuo C; Deng G; Chen Z; Yin S; Gao Z; Piccioni M; Tsun A; Cai S; Zheng SG; Zhang Y; Li B
J Biol Chem; 2014 Sep; 289(39):26872-26881. PubMed ID: 25096571
[TBL] [Abstract][Full Text] [Related]
6. Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.
Watford WT; Wang CC; Tsatsanis C; Mielke LA; Eliopoulos AG; Daskalakis C; Charles N; Odom S; Rivera J; O'Shea J; Tsichlis PN
J Immunol; 2010 Jan; 184(1):105-13. PubMed ID: 19955521
[TBL] [Abstract][Full Text] [Related]
7. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.
Watford WT; Hissong BD; Durant LR; Yamane H; Muul LM; Kanno Y; Tato CM; Ramos HL; Berger AE; Mielke L; Pesu M; Solomon B; Frucht DM; Paul WE; Sher A; Jankovic D; Tsichlis PN; O'Shea JJ
J Exp Med; 2008 Nov; 205(12):2803-12. PubMed ID: 19001140
[TBL] [Abstract][Full Text] [Related]
8. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
Shao TY; Hsu LH; Chien CH; Chiang BL
Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
Front Immunol; 2021; 12():637630. PubMed ID: 33717186
[No Abstract] [Full Text] [Related]
10. Attenuation of canonical NF-κB signaling maintains function and stability of human Treg.
Ziegler LS; Gerner MC; Schmidt RLJ; Trapin D; Steinberger P; Pickl WF; Sillaber C; Egger G; Schwarzinger I; Schmetterer KG
FEBS J; 2021 Jan; 288(2):640-662. PubMed ID: 32386462
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of MEK1 promotes Treg cell instability in vivo.
Guo J; Zhang J; Zhang X; Zhang Z; Wei X; Zhou X
J Biol Chem; 2014 Dec; 289(51):35139-48. PubMed ID: 25361764
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
[TBL] [Abstract][Full Text] [Related]
13. IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function.
Huang W; Jeong AR; Kannan AK; Huang L; August A
J Immunol; 2014 Sep; 193(5):2267-72. PubMed ID: 25063868
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.
Dominitzki S; Fantini MC; Neufert C; Nikolaev A; Galle PR; Scheller J; Monteleone G; Rose-John S; Neurath MF; Becker C
J Immunol; 2007 Aug; 179(4):2041-5. PubMed ID: 17675459
[TBL] [Abstract][Full Text] [Related]
15. Activation of Gonadotropin-releasing Hormone Receptor Impedes the Immunosuppressive Activity of Decidual Regulatory T Cells via Deactivating the Mechanistic Target of Rapamycin Signaling.
Wang X; Zhong L; Liu Q; Cai P; Zhang P; Lu Z; Li X; Liu J
Immunol Invest; 2022 Jul; 51(5):1330-1346. PubMed ID: 34132158
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
17. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
18. mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.
Huijts CM; Schneiders FL; Garcia-Vallejo JJ; Verheul HM; de Gruijl TD; van der Vliet HJ
J Immunol; 2015 Sep; 195(5):2038-45. PubMed ID: 26238486
[TBL] [Abstract][Full Text] [Related]
19. Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps.
Xu G; Xia J; Hua X; Zhou H; Yu C; Liu Z; Cai K; Shi J; Li H
Respir Res; 2009 Feb; 10(1):13. PubMed ID: 19250527
[TBL] [Abstract][Full Text] [Related]
20. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
Turner MS; Kane LP; Morel PA
J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
